Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis

British Journal of Pharmacology
Shin Yoshino, Nobuaki Mizutani

Abstract

Fab fragments (Fabs) of antibodies have the ability to bind to specific allergens but lack the Fc portion that exerts effector functions via binding to receptors including FcεR1 on mast cells. In the present study, we investigated whether intranasal administration of the effector function-lacking Fabs of a monoclonal antibody IgG1 (mAb, P1-8) to the major allergen Cry j1 of Japanese cedar pollen (JCP) suppressed JCP-induced allergic rhinitis in mice. Balb/c mice sensitized with JCP on days 0 and 14 were challenged intranasally with the pollen on days 28, 29, 30 and 35. Fabs prepared by the digestion of P1-8 with papain were also administered intranasally 15 min before each JCP challenge. Intranasal administration of P1-8 Fabs was followed by marked suppression of sneezing and nasal rubbing in mice with JCP-induced allergic rhinitis. The suppression of these allergic symptoms by P1-8 Fabs was associated with decreases in mast cells and eosinophils and decreased hyperplasia of goblet cells in the nasal mucosa. These results demonstrated that intranasal exposure to P1-8 Fabs was effective in suppressing JCP-induced allergic rhinitis in mice, suggesting that allergen-specific mAb Fabs might be used as a tool to regulate allergic po...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jul 5, 1992·The New England Journal of Medicine·A D WoolfF H Lovejoy
May 1, 1988·Scandinavian Journal of Immunology·S ElsayedM B Haugstad
Dec 1, 1989·The Journal of Allergy and Clinical Immunology·F E Simons
Jul 13, 2001·The Journal of Allergy and Clinical Immunology·D P Skoner
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J R MacKenzieP S Foster
Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Larry Borish
Nov 24, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Robert J Flanagan, Alison L Jones
Mar 5, 2005·International Archives of Allergy and Immunology·Yoshihiro KanekoAkira Eboshida
Mar 19, 2008·Clinical Drug Investigation·Christine De VosRossen Boev
Jul 25, 2008·Nature·Stephen J GalliAdrian M Piliponsky
Jun 18, 2009·Inflammation & Allergy Drug Targets·Cemal CingiAlpen Nacar
Jul 8, 2010·The Journal of Gene Medicine·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 17, 2010·The Journal of Physiology·UNKNOWN NC3Rs Reporting Guidelines Working Group
Jul 24, 2010·British Journal of Pharmacology·Carol KilkennyUNKNOWN NC3Rs Reporting Guidelines Working Group
Oct 16, 2010·British Journal of Pharmacology·S YoshinoH Kuramoto
Jan 25, 2011·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G Passalacqua, G W Canonica
Jun 7, 2011·The Journal of Allergy and Clinical Immunology·Sevgi KelesIsil Barlan
Aug 21, 2012·American Journal of Respiratory Cell and Molecular Biology·Jonathan HachaDidier D Cataldo
Dec 18, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yoshiki ShiraishiErwin W Gelfand
Apr 6, 2013·The Journal of Allergy and Clinical Immunology·Janine DretzkeCatherine Meads
Jun 5, 2013·American Journal of Rhinology & Allergy·Russell A Settipane, Christina Schwindt
Nov 16, 2013·Nucleic Acids Research·Adam J PawsonUNKNOWN NC-IUPHAR
Dec 24, 2013·The Journal of Allergy and Clinical Immunology·Takechiyo YamadaShigeharu Fujieda
Mar 4, 2014·The Journal of Allergy and Clinical Immunology·Thomas B Casale, Jeffrey R Stokes
May 14, 2014·Respiration; International Review of Thoracic Diseases·Markus Solèr
Jun 13, 2014·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Yozo Saito
Jun 14, 2014·Chemical Immunology and Allergy·Niels Mygind
Sep 23, 2014·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·George V GuibasEvangelia Spandou
May 13, 2015·British Journal of Pharmacology·John C McGrath, Elliot Lilley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.